Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2016-05-20 | The following table sets forth information for our current directors: Name Age Position Vijay B. Samant 63 Director |
| 2017-07-24 | Vijay B. Samant has served as a member of our Board of Directors since November 2015. ... Our Audit Committee consists of Louis Drapeau, Michael S. Perry and Vijay Samant. ... The Board of Directors has an Audit Committee, a Compensation Committee and a Nominating and Corporate Governance Committee. ... The following table and related footnotes show the compensation paid during the year ended December 31, 2016 to our non-employee directors, other than Ms. Johnson whose 2016 compensation is set forth above under Executive Compensation above. ... Vijay Samant 46,000 |
| 2018-11-09 | Vijay B. Samant has served as a member of our Board of Directors since November 2015. Since November 2000, Mr. Samant has served as President and Chief Executive Officer of Vical, Inc., a developer of biopharmaceutical products for the prevention and treatment of chronic life-threatening infectious diseases. ... The Nominating and Corporate Governance Committee and the Board of Directors believe that Mr. Samant’s significant experience leading biopharmaceutical product development companies, as well his significant sales, marketing, operations, and business development expertise within the biotechnology and pharmaceutical industries, qualifies him to serve on our Board of Directors. |
Data sourced from SEC filings. Last updated: 2026-02-03